实用肝脏病杂志
實用肝髒病雜誌
실용간장병잡지
JOURNAL OF CLINICAL HEPATOLOGY
2015年
2期
124-127
,共4页
吴普照%张跃伟%周军%赵广生%刘影%李闯%唐顺雄%赵旭
吳普照%張躍偉%週軍%趙廣生%劉影%李闖%唐順雄%趙旭
오보조%장약위%주군%조엄생%류영%리틈%당순웅%조욱
肝细胞癌%经导管肝动脉化疗栓塞%明胶海绵微粒%自发性破裂%止血
肝細胞癌%經導管肝動脈化療栓塞%明膠海綿微粒%自髮性破裂%止血
간세포암%경도관간동맥화료전새%명효해면미립%자발성파렬%지혈
Hepatocellular carcinoma%TACE%Gelatin sponge microparticles%Spontaneous rupture%Hemostasis
目的:回顾性分析应用不同直径明胶海绵微粒(GSMs)作为栓塞剂,经导管肝动脉化疗栓塞(TACE)治疗肝癌破裂出血患者的疗效及安全性。方法收集2010年8月~2013年12月期间,我院11例经GSMs-TACE治疗的肝癌自发性破裂出血患者的临床资料;分别于GSMs-TACE治疗后1、3和6 m复查CT和甲胎蛋白(AFP),按照改良实体瘤疗效评价标准(mRECIST 1.1)和AFP水平评价治疗反应。结果随访1~6 m (平均5 m),所有GSMs-TACE治疗患者均得以成功止血,无因技术原因所致相关并发症发生;术后1、3和6 m生存率分别为90.9%(10/11)、72.7%(8/11)和63.6%(7/11);客观有效率(ORR)分别为70%、75%和71.4%;术后并发症主要有疼痛(100%)、恶心呕吐(73%)和发热(54.5%),其中2例分别于GSMs-TACE术后第10 d和30 d行外科手术切除肿瘤。结论 GSMs-TACE治疗肝癌自发性破裂出血安全有效,即能达到立即有效止血的目的,还能够提高患者近期生存率,为后续治疗创造有利条件。
目的:迴顧性分析應用不同直徑明膠海綿微粒(GSMs)作為栓塞劑,經導管肝動脈化療栓塞(TACE)治療肝癌破裂齣血患者的療效及安全性。方法收集2010年8月~2013年12月期間,我院11例經GSMs-TACE治療的肝癌自髮性破裂齣血患者的臨床資料;分彆于GSMs-TACE治療後1、3和6 m複查CT和甲胎蛋白(AFP),按照改良實體瘤療效評價標準(mRECIST 1.1)和AFP水平評價治療反應。結果隨訪1~6 m (平均5 m),所有GSMs-TACE治療患者均得以成功止血,無因技術原因所緻相關併髮癥髮生;術後1、3和6 m生存率分彆為90.9%(10/11)、72.7%(8/11)和63.6%(7/11);客觀有效率(ORR)分彆為70%、75%和71.4%;術後併髮癥主要有疼痛(100%)、噁心嘔吐(73%)和髮熱(54.5%),其中2例分彆于GSMs-TACE術後第10 d和30 d行外科手術切除腫瘤。結論 GSMs-TACE治療肝癌自髮性破裂齣血安全有效,即能達到立即有效止血的目的,還能夠提高患者近期生存率,為後續治療創造有利條件。
목적:회고성분석응용불동직경명효해면미립(GSMs)작위전새제,경도관간동맥화료전새(TACE)치료간암파렬출혈환자적료효급안전성。방법수집2010년8월~2013년12월기간,아원11례경GSMs-TACE치료적간암자발성파렬출혈환자적림상자료;분별우GSMs-TACE치료후1、3화6 m복사CT화갑태단백(AFP),안조개량실체류료효평개표준(mRECIST 1.1)화AFP수평평개치료반응。결과수방1~6 m (평균5 m),소유GSMs-TACE치료환자균득이성공지혈,무인기술원인소치상관병발증발생;술후1、3화6 m생존솔분별위90.9%(10/11)、72.7%(8/11)화63.6%(7/11);객관유효솔(ORR)분별위70%、75%화71.4%;술후병발증주요유동통(100%)、악심구토(73%)화발열(54.5%),기중2례분별우GSMs-TACE술후제10 d화30 d행외과수술절제종류。결론 GSMs-TACE치료간암자발성파렬출혈안전유효,즉능체도립즉유효지혈적목적,환능구제고환자근기생존솔,위후속치료창조유리조건。
Objective To retrospectively analyze the safety and efficacy of transarterial chemoembolization (TACE) by using gelatin sponge microparticles(GSMs) in different diameters in patients with spontaneous rupture of hepatocellular carcinoma(HCC). Methods From August 2010 to December 2013,11 patients with spontaneous rup-ture of HCC received GSMs-TACE in Zhongshan Hospital Affiliated to Dalian University. CT scanning and determi-nation of serum AFP levels were performed 1,3 and 6 months after initial GSMs-TACE,and tumor response was e-valuated according to mRECIST 1.1 criteria and AFP levels. Results The 11 patients after GSMs-TACE were Fol-lowed-up for 1 to 6 months with a mean range of 5 months. 11 patients receiving GSMs-TACE achieved successful rapid hemostasis without technique-related complications;the survival rates at 1,3 and 6 month(s) were 90.9%(10/11),72.7% (8/11) and 63.6% (7/11),respectively,and the objective effective rates were 70.0%,75.0%,71.4%,re-spectively;the postoperative complications mainly included local pain(100%),nausea and vomiting (73.0%),fever(54. 5%);two patient received hepatectomy 10 days and 30 days after GSMs-TACE,respectively. Conclusion TACE using GSMs of different diameters is safe and effective for patients with spontaneous rupture of HCC in the pur-pose of achieving hemostasis,improving survival rates and even getting the subsequent surgical operation.